
Embecta Corp.
EMBCV
Updated: 24/09/2026, 22:15:28
No historical data available
Embecta Corp. operates as a medical device company, primarily dedicated to improving the health and overall well-being of individuals living with diabetes. Its diverse product range encompasses essential items like pen needles, syringes, and various safety devices, alongside digital tools specifically designed to assist with diabetes self-management. The company distributes its offerings mainly through wholesalers and distributors, reaching customers across the United States and internationally. Embecta Corp. was established in 1924 and is headquartered in Parsippany, New Jersey.
No summaries found.
- Share price
- $33.33
- Market cap
- $1.91B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- 2,029
- IPO date
- 21/03/2022
- Beta
- 0
- Last dividend
- $0.00
- Day range
- $33.33 – $38.21
- 52-week range
- $27.20 – $49.00
- 1-day performance
- -9.33%
- 1-year performance
- 22.54%
- Current drawdown (1Y)
- -31.98%
- CIK
- 0001872789
- CUSIP
- N/A
- ISIN
- N/A
- Created
- 07/12/2025, 03:46:06
- Last update
- 24/09/2026, 22:15:28
Track Embecta Corp. with an AI analyst
See which prediction-market events move EMBCV, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.